BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26851687)

  • 21. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
    Ziadi A; Saliba I
    Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conus medullaris and cauda equina tumors: clinical presentation, prognosis, and outcome after surgical treatment: clinical article.
    Wostrack M; Shiban E; Obermueller T; Gempt J; Meyer B; Ringel F
    J Neurosurg Spine; 2014 Mar; 20(3):335-43. PubMed ID: 24438427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifocal intradural extramedullary ependymoma. Case report.
    Iunes EA; Stávale JN; de Cássia Caldas Pessoa R; Ansai R; Onishi FJ; de Paiva Neto MA; de Pádua Bonatelli A; Cavalheiro S; Fleury Malheiros SM
    J Neurosurg Spine; 2011 Jan; 14(1):65-70. PubMed ID: 21142461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2.
    J Neurosurg Spine; 2017 Apr; 26(4):474-482. PubMed ID: 27982762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
    Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
    J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibromatosis 2 in the pediatric age group.
    Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
    Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal MR findings in neurofibromatosis types 1 and 2.
    Egelhoff JC; Bates DJ; Ross JS; Rothner AD; Cohen BH
    AJNR Am J Neuroradiol; 1992; 13(4):1071-7. PubMed ID: 1636515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schwannomatosis, sporadic schwannomatosis, and familial schwannomatosis: a surgical series with long-term follow-up. Clinical article.
    Gonzalvo A; Fowler A; Cook RJ; Little NS; Wheeler H; McDonald KL; Biggs MT
    J Neurosurg; 2011 Mar; 114(3):756-62. PubMed ID: 20932094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradural extramedullary spinal ependymoma: a benign pathology?
    Robles SG; Saldaña C; Boto GR; Martinez A; Zamarron AP; Jorquera M; Mata P
    Spine (Phila Pa 1976); 2005 May; 30(9):E251-4. PubMed ID: 15864145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal neurinomas: retrospective analysis and long-term outcome of 179 consecutively operated cases and review of the literature.
    Conti P; Pansini G; Mouchaty H; Capuano C; Conti R
    Surg Neurol; 2004 Jan; 61(1):34-43; discussion 44. PubMed ID: 14706374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramedullary tumours in patients with neurofibromatosis type 2: MRI features associated with a favourable prognosis.
    Rennie AT; Side L; Kerr RS; Anslow P; Pretorius P
    Clin Radiol; 2008 Feb; 63(2):193-200. PubMed ID: 18194696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramedullary spinal cord tumors in neurofibromatosis.
    Lee M; Rezai AR; Freed D; Epstein FJ
    Neurosurgery; 1996 Jan; 38(1):32-7. PubMed ID: 8747948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
    Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
    J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosurgery for benign intradural spinal tumors.
    Gerszten PC; Burton SA; Ozhasoglu C; McCue KJ; Quinn AE
    Neurosurgery; 2008 Apr; 62(4):887-95; discussion 895-6. PubMed ID: 18496194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.
    Garcés-Ambrossi GL; McGirt MJ; Mehta VA; Sciubba DM; Witham TF; Bydon A; Wolinksy JP; Jallo GI; Gokaslan ZL
    J Neurosurg Spine; 2009 Nov; 11(5):591-9. PubMed ID: 19929363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neurofibromatosis type 2].
    Goutagny S; Bouccara D; Bozorg-Grayeli A; Sterkers O; Kalamarides M
    Rev Neurol (Paris); 2007 Sep; 163(8-9):765-77. PubMed ID: 17878803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth Dynamics of Intracranial Tumors in Patients with Neurofibromatosis Type 2.
    Lawson McLean AC; Rosahl SK
    World Neurosurg; 2017 Feb; 98():152-161. PubMed ID: 27777160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intramedullary spinal cord tumors and neurofibromatosis].
    Kushel' YV; Belova YD; Tekoev AR
    Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(1):70-73. PubMed ID: 28291216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lumbosacral ependymomas: a review of the management of intradural and extradural tumors.
    Fassett DR; Schmidt MH
    Neurosurg Focus; 2003 Nov; 15(5):E13. PubMed ID: 15323470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.